Literature DB >> 26342272

Racialized risk environments in a large sample of people who inject drugs in the United States.

Hannah L F Cooper1, Sabriya Linton2, Mary E Kelley2, Zev Ross3, Mary E Wolfe2, Yen-Tyng Chen2, Maria Zlotorzynska2, Josalin Hunter-Jones2, Samuel R Friedman4, Don Des Jarlais5, Salaam Semaan6, Barbara Tempalski4, Elizabeth DiNenno6, Dita Broz6, Cyprian Wejnert6, Gabriela Paz-Bailey6.   

Abstract

BACKGROUND: Substantial racial/ethnic disparities exist in HIV infection among people who inject drugs (PWID) in many countries. To strengthen efforts to understand the causes of disparities in HIV-related outcomes and eliminate them, we expand the "Risk Environment Model" to encompass the construct "racialized risk environments," and investigate whether PWID risk environments in the United States are racialized. Specifically, we investigate whether black and Latino PWID are more likely than white PWID to live in places that create vulnerability to adverse HIV-related outcomes.
METHODS: As part of the Centers for Disease Control and Prevention's National HIV Behavioral Surveillance, 9170 PWID were sampled from 19 metropolitan statistical areas (MSAs) in 2009. Self-reported data were used to ascertain PWID race/ethnicity. Using Census data and other administrative sources, we characterized features of PWID risk environments at four geographic scales (i.e., ZIP codes, counties, MSAs, and states). Means for each feature of the risk environment were computed for each racial/ethnic group of PWID, and were compared across racial/ethnic groups.
RESULTS: Almost universally across measures, black PWID were more likely than white PWID to live in environments associated with vulnerability to adverse HIV-related outcomes. Compared to white PWID, black PWID lived in ZIP codes with higher poverty rates and worse spatial access to substance abuse treatment and in counties with higher violent crime rates. Black PWID were less likely to live in states with laws facilitating sterile syringe access (e.g., laws permitting over-the-counter syringe sales). Latino/white differences in risk environments emerged at the MSA level (e.g., Latino PWID lived in MSAs with higher drug-related arrest rates).
CONCLUSION: PWID risk environments in the US are racialized. Future research should explore the implications of this racialization for racial/ethnic disparities in HIV-related outcomes, using appropriate methods.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical race theory; HIV; Injection drug use; National HIV Behavioral Surveillance; Residence characteristics; Risk environments

Mesh:

Year:  2015        PMID: 26342272      PMCID: PMC4715941          DOI: 10.1016/j.drugpo.2015.07.015

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  52 in total

1.  HIV infection and HIV-associated behaviors among injecting drug users - 20 cities, United States, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-03-02       Impact factor: 17.586

2.  Racial residential segregation and rates of gonorrhea in the United States, 2003-2007.

Authors:  Katie B Biello; Trace Kershaw; Robert Nelson; Matthew Hogben; Jeannette Ickovics; Linda Niccolai
Journal:  Am J Public Health       Date:  2012-05-17       Impact factor: 9.308

3.  "Over here, it's just drugs, women and all the madness": The HIV risk environment of clients of female sex workers in Tijuana, Mexico.

Authors:  Shira M Goldenberg; Steffanie A Strathdee; Manuel Gallardo; Tim Rhodes; Karla D Wagner; Thomas L Patterson
Journal:  Soc Sci Med       Date:  2011-03-03       Impact factor: 4.634

4.  Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures.

Authors:  William T Robinson; Jan M H Risser; Shanell McGoy; Adam B Becker; Hafeez Rehman; Mary Jefferson; Vivian Griffin; Marcia Wolverton; Stephanie Tortu
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

5.  Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors.

Authors:  Hannah Lf Cooper; Don C Des Jarlais; Barbara Tempalski; Brian H Bossak; Zev Ross; Samuel R Friedman
Journal:  Health Place       Date:  2011-09-28       Impact factor: 4.078

Review 6.  Social and structural factors associated with HIV disease progression among illicit drug users: a systematic review.

Authors:  Michael-John S Milloy; Brandon D L Marshall; Thomas Kerr; Jane Buxton; Tim Rhodes; Julio Montaner; Evan Wood
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

7.  Spatial access to syringe exchange programs and pharmacies selling over-the-counter syringes as predictors of drug injectors' use of sterile syringes.

Authors:  Hannah L F Cooper; Don C Des Jarlais; Zev Ross; Barbara Tempalski; Brian Bossak; Samuel R Friedman
Journal:  Am J Public Health       Date:  2010-11-18       Impact factor: 9.308

8.  Place, not race: disparities dissipate in southwest Baltimore when blacks and whites live under similar conditions.

Authors:  Thomas LaVeist; Keshia Pollack; Roland Thorpe; Ruth Fesahazion; Darrell Gaskin
Journal:  Health Aff (Millwood)       Date:  2011-10       Impact factor: 6.301

Review 9.  Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs.

Authors:  Don C D Jarlais; Hannah L F Cooper; Heidi Bramson; Sherry Deren; Angelos Hatzakis; Holly Hagan
Journal:  Curr Opin HIV AIDS       Date:  2012-07       Impact factor: 4.283

10.  Comparing respondent-driven sampling and targeted sampling methods of recruiting injection drug users in San Francisco.

Authors:  Alex H Kral; Mohsen Malekinejad; Jason Vaudrey; Alexis N Martinez; Jennifer Lorvick; Willi McFarland; H Fisher Raymond
Journal:  J Urban Health       Date:  2010-09       Impact factor: 3.671

View more
  24 in total

1.  Rural risk environments for hepatitis c among young adults in appalachian kentucky.

Authors:  David H Cloud; Umedjon Ibragimov; Nadya Prood; April M Young; Hannah L F Cooper
Journal:  Int J Drug Policy       Date:  2019-05-18

2.  Population-Attributable Risk Percentages for Racialized Risk Environments.

Authors:  Hannah L F Cooper; Kimberly Jacob Arriola; Regine Haardörfer; Colleen M McBride
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

3.  Mortgage Discrimination and Racial/Ethnic Concentration Are Associated with Same-Race/Ethnicity Partnering among People Who Inject Drugs in 19 US Cities.

Authors:  Sabriya L Linton; Hannah L F Cooper; Yen-Tyng Chen; Mohammed A Khan; Mary E Wolfe; Zev Ross; Don C Des Jarlais; Samuel R Friedman; Barbara Tempalski; Dita Broz; Salaam Semaan; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  J Urban Health       Date:  2020-02       Impact factor: 3.671

4.  Racial/Ethnic Disparities at the End of an HIV Epidemic: Persons Who Inject Drugs in New York City, 2011-2015.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Courtney McKnight; Jonathan Feelemyer; Susan Tross; David Perlman; Samuel Friedman; Aimee Campbell
Journal:  Am J Public Health       Date:  2017-05-18       Impact factor: 9.308

5.  Structural inequalities drive late HIV diagnosis: The role of black racial concentration, income inequality, socioeconomic deprivation, and HIV testing.

Authors:  Yusuf Ransome; Ichiro Kawachi; Sarah Braunstein; Denis Nash
Journal:  Health Place       Date:  2016-10-19       Impact factor: 4.078

6.  The intersectional risk environment of people who use drugs.

Authors:  Alexandra B Collins; Jade Boyd; Hannah L F Cooper; Ryan McNeil
Journal:  Soc Sci Med       Date:  2019-06-22       Impact factor: 4.634

7.  Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.

Authors:  Sabriya L Linton; Hannah L F Cooper; Mary E Kelley; Conny C Karnes; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Catlainn Sionean; Elizabeth DiNenno; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  Ann Epidemiol       Date:  2016-08-08       Impact factor: 3.797

8.  Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky.

Authors:  Hannah Lf Cooper; David H Cloud; Patricia R Freeman; Monica Fadanelli; Travis Green; Connor Van Meter; Stephanie Beane; Umedjon Ibragimov; April M Young
Journal:  Int J Drug Policy       Date:  2020-03-26

9.  Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals.

Authors:  Ryan McNeil; Thomas Kerr; Bernie Pauly; Evan Wood; Will Small
Journal:  Addiction       Date:  2016-01-08       Impact factor: 6.526

10.  A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs.

Authors:  Kristina T Phillips; Catherine Stewart; Bradley J Anderson; Jane M Liebschutz; Debra S Herman; Michael D Stein
Journal:  Drug Alcohol Depend       Date:  2021-02-27       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.